LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 3479

Search options

  1. Article ; Online: Lumasiran: A Review in Primary Hyperoxaluria Type 1.

    Kang, Connie

    Drugs

    2024  Volume 84, Issue 2, Page(s) 219–226

    Abstract: Lumasiran ( ... ...

    Abstract Lumasiran (Oxlumo
    MeSH term(s) Humans ; Hyperoxaluria, Primary/drug therapy ; Oxalates ; RNA, Small Interfering ; Randomized Controlled Trials as Topic
    Chemical Substances lumasiran (RZT8C352O1) ; Oxalates ; RNA, Small Interfering
    Language English
    Publishing date 2024-01-22
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 120316-2
    ISSN 1179-1950 ; 0012-6667
    ISSN (online) 1179-1950
    ISSN 0012-6667
    DOI 10.1007/s40265-023-01987-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Correction: Lumasiran: A Review in Primary Hyperoxaluria Type 1.

    Kang, Connie

    Drugs

    2024  Volume 84, Issue 3, Page(s) 371

    Language English
    Publishing date 2024-03-15
    Publishing country New Zealand
    Document type Published Erratum
    ZDB-ID 120316-2
    ISSN 1179-1950 ; 0012-6667
    ISSN (online) 1179-1950
    ISSN 0012-6667
    DOI 10.1007/s40265-024-02014-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Sacituzumab Govitecan: A Review in Unresectable or Metastatic HR+/HER2- Breast Cancer.

    Kang, Connie

    Targeted oncology

    2024  Volume 19, Issue 2, Page(s) 289–296

    Abstract: Sacituzumab govitecan ( ... ...

    Abstract Sacituzumab govitecan (TRODELVY
    MeSH term(s) Adult ; Humans ; Female ; Breast Neoplasms/pathology ; Quality of Life ; Camptothecin/pharmacology ; Camptothecin/analogs & derivatives ; Immunoconjugates/therapeutic use ; Neutropenia ; Diarrhea/chemically induced ; Antibodies, Monoclonal, Humanized
    Chemical Substances sacituzumab govitecan (M9BYU8XDQ6) ; Camptothecin (XT3Z54Z28A) ; Immunoconjugates ; Antibodies, Monoclonal, Humanized
    Language English
    Publishing date 2024-03-06
    Publishing country France
    Document type Journal Article ; Review
    ZDB-ID 2222136-0
    ISSN 1776-260X ; 1776-2596
    ISSN (online) 1776-260X
    ISSN 1776-2596
    DOI 10.1007/s11523-024-01036-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Danicopan: First Approval.

    Kang, Connie

    Drugs

    2024  

    Abstract: Danicopan ( ... ...

    Abstract Danicopan (Voydeya
    Language English
    Publishing date 2024-03-26
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 120316-2
    ISSN 1179-1950 ; 0012-6667
    ISSN (online) 1179-1950
    ISSN 0012-6667
    DOI 10.1007/s40265-024-02023-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Ruxolitinib Cream 1.5%: A Review in Non-Segmental Vitiligo.

    Kang, Connie

    Drugs

    2024  

    Abstract: Topical ruxolitinib 1.5% cream ( ... ...

    Abstract Topical ruxolitinib 1.5% cream (Opzelura
    Language English
    Publishing date 2024-04-16
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 120316-2
    ISSN 1179-1950 ; 0012-6667
    ISSN (online) 1179-1950
    ISSN 0012-6667
    DOI 10.1007/s40265-024-02027-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Trastuzumab Deruxtecan: A Review in Gastric or Gastro-Oesophageal Junction Adenocarcinoma.

    Kang, Connie

    Targeted oncology

    2023  Volume 18, Issue 6, Page(s) 981–989

    Abstract: Trastuzumab deruxtecan ( ... ...

    Abstract Trastuzumab deruxtecan (Enhertu
    MeSH term(s) Adult ; Humans ; Antibodies, Monoclonal, Humanized/therapeutic use ; Stomach Neoplasms ; Trastuzumab/adverse effects ; Receptor, ErbB-2/therapeutic use ; Immunoconjugates/therapeutic use ; Adenocarcinoma/drug therapy ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
    Chemical Substances trastuzumab deruxtecan (5384HK7574) ; Antibodies, Monoclonal, Humanized ; Trastuzumab (P188ANX8CK) ; Receptor, ErbB-2 (EC 2.7.10.1) ; Immunoconjugates
    Language English
    Publishing date 2023-10-03
    Publishing country France
    Document type Journal Article ; Review
    ZDB-ID 2222136-0
    ISSN 1776-260X ; 1776-2596
    ISSN (online) 1776-260X
    ISSN 1776-2596
    DOI 10.1007/s11523-023-00998-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Retifanlimab: First Approval.

    Kang, Connie

    Drugs

    2023  Volume 83, Issue 8, Page(s) 731–737

    Abstract: Retifanlimab (retifanlimab-dlwr; ... ...

    Abstract Retifanlimab (retifanlimab-dlwr; ZYNYZ
    MeSH term(s) Adult ; Humans ; Antibodies, Monoclonal, Humanized/pharmacology ; Antibodies, Monoclonal, Humanized/therapeutic use ; Carcinoma, Merkel Cell/drug therapy ; Drug Approval ; Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal/therapeutic use ; Immune Checkpoint Inhibitors/therapeutic use ; Skin Neoplasms/drug therapy ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use
    Chemical Substances Antibodies, Monoclonal, Humanized ; Antibodies, Monoclonal ; Immune Checkpoint Inhibitors ; Antineoplastic Agents
    Language English
    Publishing date 2023-04-25
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 120316-2
    ISSN 1179-1950 ; 0012-6667
    ISSN (online) 1179-1950
    ISSN 0012-6667
    DOI 10.1007/s40265-023-01884-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Olutasidenib: First Approval.

    Kang, Connie

    Drugs

    2023  Volume 83, Issue 4, Page(s) 341–346

    Abstract: Olutasidenib ( ... ...

    Abstract Olutasidenib (REZLIDHIA
    MeSH term(s) Adult ; Humans ; Isocitrate Dehydrogenase/genetics ; Leukemia, Myeloid, Acute/drug therapy ; Mutation ; Pyridines/pharmacology ; Pyridines/therapeutic use ; Quinolines/therapeutic use
    Chemical Substances Isocitrate Dehydrogenase (EC 1.1.1.41) ; olutasidenib (0T4IMT8S5Z) ; Pyridines ; Quinolines ; IDH1 protein, human (EC 1.1.1.42.)
    Language English
    Publishing date 2023-02-27
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 120316-2
    ISSN 1179-1950 ; 0012-6667
    ISSN (online) 1179-1950
    ISSN 0012-6667
    DOI 10.1007/s40265-023-01844-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Ravulizumab: A Review in Generalised Myasthenia Gravis.

    Kang, Connie

    Drugs

    2023  Volume 83, Issue 8, Page(s) 717–723

    Abstract: Ravulizumab ( ... ...

    Abstract Ravulizumab (ULTOMIRIS
    MeSH term(s) Adult ; Humans ; Activities of Daily Living ; Myasthenia Gravis/drug therapy ; Antibodies, Monoclonal, Humanized/adverse effects ; Receptors, Cholinergic ; Immunologic Factors/therapeutic use ; Complement Inactivating Agents/therapeutic use
    Chemical Substances ravulizumab (C3VX249T6L) ; Antibodies, Monoclonal, Humanized ; Receptors, Cholinergic ; Immunologic Factors ; Complement Inactivating Agents
    Language English
    Publishing date 2023-05-11
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 120316-2
    ISSN 1179-1950 ; 0012-6667
    ISSN (online) 1179-1950
    ISSN 0012-6667
    DOI 10.1007/s40265-023-01877-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Avacincaptad Pegol: First Approval.

    Kang, Connie

    Drugs

    2023  Volume 83, Issue 15, Page(s) 1447–1453

    Abstract: Avacincaptad pegol (IZERVAY™; formerly ... ...

    Abstract Avacincaptad pegol (IZERVAY™; formerly Zimura
    MeSH term(s) Humans ; Geographic Atrophy ; Macular Degeneration/drug therapy ; Complement Inactivating Agents ; Complement C5
    Chemical Substances Complement Inactivating Agents ; Complement C5
    Language English
    Publishing date 2023-10-09
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 120316-2
    ISSN 1179-1950 ; 0012-6667
    ISSN (online) 1179-1950
    ISSN 0012-6667
    DOI 10.1007/s40265-023-01948-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top